Rapid Rebound of a Preexisting CXCR4-tropic Human Immunodeficiency Virus Variant After Allogeneic Transplantation With CCR5 Δ32 Homozygous Stem Cells
Author(s) -
Jens Verheyen,
Alexander Thielen,
Nadine Lübke,
Miriam Dirks,
Marek Widera,
Ulf Dittmer,
Lambros Kordelas,
Martin Däumer,
Dorien C. M. de Jong,
Annemarie M. J. Wensing,
Rolf Kaiser,
Monique Nijhuis,
Stefan Eßer
Publication year - 2018
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciy565
Subject(s) - transplantation , cxcr4 , stem cell , medicine , virology , human immunodeficiency virus (hiv) , virus , immunology , viral disease , lentivirus , hematopoietic stem cell transplantation , immunodeficiency , severe combined immunodeficiency , biology , genetics , gene , chemokine , inflammation , immune system
Allogeneic stem cell transplantation (alloSCT) of homozygous CCR5 Δ32 stem cells once resulted in the cure of human immunodeficiency virus (HIV) infection. We have recently reported a viral breakthrough in a similar setting. Here, we demonstrate that the rapid rebound after alloSCT was related to a highly replicative CXCR4-tropic HIV variant, which could already be detected before alloSCT.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom